EARLY NEONATAL INFECTION IN INFANTS BORN TO MOTHERS INFECTED WITH GROUP B STREPTOCOCCUS PHENOTYPE MLSB USING ANTIBIOTICS FOR PRENATAL INFECTION PROPHYLAXIS AT HUNG VUONG HOSPITAL

Thị Thu Sương Nguyễn, Thị Hằng Phan, Hữu Trung Nguyễn

Main Article Content

Abstract

Objective: The rate of early neonatal infection in infants whose mothers were infected with group B Streptococcus with the MLSB phenotype who gave birth at Hung Vuong Hospital and used antibiotics to prevent infection before birth. Method: A cross-sectional study describing a survey of 483 pregnant women infected with GBS with the MLSB phenotype who gave birth at Hung Vuong Hospital and used antibiotics to prevent infection at least 4 hours before birth during the period from August 1, 2023 to March 31, 2024. Results: Pregnant women aged 25 - < 30 years old: accounted for the highest rate of 35.61%. Pregnancies with GBS with the MLSB phenotype had a rate of premature rupture of membranes of 18.84%. Ampicillin was the most frequently used antibiotic, accounting for 99.17%. 99.79% of pregnant women infected with GBS with the MLSB phenotype had antibiotic susceptibility results to ampicillin. The number of normal newborns, without signs of infection accounted for (89.86%), the rate of early neonatal sepsis was 10.14% CI 95% (7.46 - 12.82). Only 6 cases of early neonatal sepsis were diagnosed as definite sepsis (with positive blood culture results), accounting for 1.24%. Conclusion: Prophylactic antibiotics are effective in reducing the rate of mother-to-child transmission of GBS and reducing the rate of neonatal infection.

Article Details

References

1. Schrag, S.J. and J.R. Verani, Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine, 2013. 31: p. D20-D26.
2. Verani, J.R., L. McGee, and S.J. Schrag, Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. 2010, Department of Health and Human Services, Centers for Disease Control and ….
3. Back Ephraim, E., J. O'Grady Elisa, and D. Back Joshua, High Rates of Perinatal Group B Streptococcus Clindamycin and Erythromycin Resistance in an Upstate New York Hospital. Antimicrobial Agents and Chemotherapy, 2012. 56(2): p. 739-742.
4. Liu, Z., et al., Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China. Front Microbiol, 2023. 14: p. 1138039.
5. Sapugahawatte, D.N., et al., Colonization of Group B Streptococcus in Pregnant Women and Their Neonates from a Sri Lankan Hospital. Pathogens, 2022. 11(4).
6. Van Du, V., et al., Antimicrobial resistance in colonizing group B Streptococcus among pregnant women from a hospital in Vietnam. Scientific Reports, 2021. 11(1): p. 20845.
7. Lý, P.T., N.Q. Tuấn, and T.M. Linh, Tỷ lệ mang liên cầu khuẩn nhóm B ở 35–37 tuần thai kỳ và hiệu quả của kháng sinh dự phòng lây nhiễm trước sinh. Tạp chí Phụ sản, 2020. 18(3): p. 19-26.
8. Trang, P.T., et al., Tỷ lệ mang liên cầu nhóm B và kết quả thai kỳ ở sản phụ sinh tại Bệnh viện Phụ sản Hà Nội. Bản B của Tạp chí Khoa học và Công nghệ Việt Nam, 2023. 65(7).